FDA approves new drug to treat acromegaly
Tuesday September 4, 2007
On August 30, 2007, the U.S. Food and Drug Administration (FDA) approved Somatuline Depot (lanreotide injection, developed by Tercica) for the treatment of acromegaly, a disorder in which there is ... Read More